Skip to content
Ultra Poker Platform

Users Discontinuing Weight-Loss Jabs Put On Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise

Image of pharmaceutical injection and weighing machine
Obesity treatment involves long-term strategies.

New research indicates that people who come off popular GLP-1 drugs like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who end traditional diet and exercise plans.

Published data in a leading health publication demonstrates that while obese people frequently drop substantial amounts of their total mass while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month after stopping.

"Users buying such drugs should be cognizant of the potential of quick rebound weight gain when the therapy is stopped," cautioned lead investigator Dr. Susan Jebb.

This pace of regain suggests a return to starting weight in about 18 months.

Analyzing Approaches

The analysis, which looked at 37 of studies involving over 9,000 of participants, contrasted the effects of the injectable medications with other pills.

Scientists note that people who lose weight through dieting usually have a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.

Explaining the Fast Regain

Nutrition scientists suggest the mechanism of the jabs is key to understanding the amplified weight return.

GLP-1 drugs copy a body's own chemical called GLP-1, which controls hunger.

"Long-term administration of the hormone concentrations far above than the body's typical production may cause the body to produce less of its endogenous hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.

"Discontinuation of this medication means hunger is uncontrolled, making binge eating much more probable."

A Chronic Issue?

Medical guidelines suggest the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.

Professionals argue that, due to the likelihood of weight regain, the therapy might need to be life-long.

This view is supported by pharmaceutical companies, who state that the findings "underscore the chronic nature of excess weight," akin to managing diseases like high blood pressure.

Patient Testimonies

People who have discontinued the medication describe a intense resurgence of appetite.

"It felt as if something activating and I was suddenly ravenous," described an individual.

The struggle is exacerbated if individuals have not developed permanent dietary or behavioural modifications during therapy.

Significant Use

Figures suggest that millions of people in the UK have used these injections in the last 12 months, with interest remaining high.

  • Adoption is higher among women compared to men.
  • The 40s and 50s age group shows the greatest level of interest.
  • A large proportion access the drugs through private healthcare rather than the NHS.

Ultimately, clinicians emphasize that while GLP-1 drugs are potent agents for weight loss, they are not a permanent cure and lasting health benefits hinges on integrated lifestyle management.

By

Travis Grimes

A seasoned poker strategist and software developer with over a decade of experience in online gaming platforms and analytics.

Ultra Poker Platform

Type to search articles.